Continuum Advisory’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-280
| Closed | -$19.1K | – | 715 |
|
|
2025
Q1 | $19.1K | Sell |
280
-15
| -5% | -$1.02K | ﹤0.01% | 865 |
|
|
2024
Q4 | $22.9K | Buy |
295
+2
| +0.7% | +$156 | ﹤0.01% | 818 |
|
|
2024
Q3 | $21.9K | Buy |
293
+32
| +12% | +$2.39K | ﹤0.01% | 822 |
|
|
2024
Q2 | $29.6K | Buy |
261
+4
| +2% | +$454 | ﹤0.01% | 719 |
|
|
2024
Q1 | $32.9K | Buy |
+257
| New | +$32.9K | ﹤0.01% | 681 |
|
|
2023
Q3 | – | Sell |
-1,630
| Closed | -$209K | – | 457 |
|
|
2023
Q2 | $209K | Buy |
+1,630
| New | +$209K | 0.03% | 426 |
|
|
2022
Q1 | – | Sell |
-1,668
| Closed | -$224K | – | 381 |
|
|
2021
Q4 | $224K | Buy |
1,668
+12
| +0.7% | +$1.61K | 0.05% | 275 |
|
|
2021
Q3 | $226K | Buy |
+1,656
| New | +$226K | 0.06% | 269 |
|